Phase II trial of intraperitoneal cisplatin combined with paclitaxel in patients with ovarian, fallopian tube and primary peritoneal carcinomas

被引：0
|
作者：
Landrum, L.
Mannel, R.
McMeekin, D. [1 ]
Moore, K. [1 ]
Hyde, J.
Walker, J. [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
来源：
GYNECOLOGIC ONCOLOGY | 2010年 / 116卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
268
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [1] Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer
    Landrum, Lisa M.
    Hyde, Johnny, Jr.
    Mannel, Robert S.
    McMeekin, D. Scott
    Moore, Kathleen N.
    Walker, Joan L.
    GYNECOLOGIC ONCOLOGY, 2011, 122 (03) : 527 - 531
  • [2] A phase I trial of intravenous paclitaxel, intraperitoneal carboplatin, and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study
    Gould, N.
    Sill, M.
    Mannel, R.
    Fracasso, P.
    Thaker, P.
    DiSilvestro, P.
    Waggoner, S.
    Yamada, S.
    Armstrong, D.
    Walker, J.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S15 - S15
  • [3] Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study
    Dizon, Don S.
    Sill, Michael W.
    Gould, Natalie
    Rubin, Stephen C.
    Yamada, S. Diane
    DeBernardo, Robert L.
    Mannel, Robert S.
    Eisenhauer, Eric L.
    Duska, Linda R.
    Fracasso, Paula M.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 182 - 186
  • [4] Phase 2 trial of carboplatin, paclitaxel, and irinotecan in ovarian, fallopian tube, and primary peritoneal cancers
    Escobar, PF
    Markman, M
    Rose, P
    Zanotti, K
    Webster, K
    Belinson, J
    GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 192 - 196
  • [5] Hyperthermic Intraperitoneal Chemotherapy in the Management of Ovarian, Fallopian Tube and Peritoneal Carcinomas
    Chalif, Julia
    Wegner, Lauren
    Backes, Floor
    Chambers, Laura M.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2025, 34 (02) : 265 - 285
  • [6] Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer
    Barlin, Joyce N.
    Dao, Fanny
    Zgheib, Nadim Bou
    Ferguson, Sarah E.
    Sabbatini, Paul J.
    Hensley, Martee L.
    Bell-McGuinn, Katherine M.
    Konner, Jason
    Tew, William P.
    Aghajanian, Carol
    Chi, Dennis S.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 621 - 624
  • [7] Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: Gynecologic Oncology Group study 9921.
    Dizon, D. S.
    Sill, M.
    Gould, N. S.
    Rubin, S. C.
    Yamada, S. D.
    DeBernardo, R.
    Mannel, R. S.
    Eisenhauer, E. L.
    Duska, L. R.
    Fracasso, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas
    Somasegar, Sahana
    Weiss, Arielle S.
    Norquist, Barbara M.
    Khasnavis, Nithisha
    Radke, Marc
    Manhardt, Enna
    Pennil, Christopher
    Pennington, Kathryn P.
    Eckert, Mark A.
    Chryplewicz, Agnieszka
    Lengyel, Ernst
    Swisher, Elizabeth M.
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 130 - 133
  • [9] Phase I trial of intravenous docetaxel and intraperitoneal oxaliplatin in recurrent ovarian, fallopian tube and primary peritoneal cancer
    Zorn, K.
    Donovan, H.
    Zamboni, W.
    Edwards, R.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S134 - S134
  • [10] Intravenous/Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Carcinoma A Feasibility Study
    Nagao, Shoji
    Iwasa, Norihiro
    Kurosaki, Akira
    Nishikawa, Tadaaki
    Ohishi, Rie
    Hasegawa, Kosei
    Goto, Tomoko
    Fujiwara, Keiichi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (01) : 70 - 75
12345